A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention
Passive transfer of broadly neutralizing antibodies is showing promise in the treatment and prevention of HIV-1. One class of antibodies, the VRC01 class, appears especially promising. To improve VRC01-class antibodies, we combined structure-based design with a matrix-based approach to generate VRC0...
Gardado en:
| Principais autores: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis Group
2021-01-01
|
| Series: | mAbs |
| Assuntos: | |
| Acceso en liña: | https://www.tandfonline.com/doi/10.1080/19420862.2021.1946918 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
